Package Leaflet: Information for the user. Xalacom 50 micrograms/ml and 5 mg/ml Eye Drops, Solution Latanoprost + Timolol
|
|
- Christine Morrison
- 6 years ago
- Views:
Transcription
1 Package Leaflet: Information for the user Xalacom 50 micrograms/ml and 5 mg/ml Eye Drops, Solution Latanoprost + Timolol Read all of this leaflet carefully before you start using this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1. What Xalacom is and what it is used for 2. What you need to know before you use Xalacom 3. How to use Xalacom 4. Possible side effects 5. How to store Xalacom 6. Contents of the pack and other information 1. What Xalacom is and what it is used for Xalacom contains two medicines: latanoprost and timolol. Latanoprost belongs to a group of medicines known as prostaglandin analogues. Timolol belongs to a group of medicines known as beta-blockers. Latanoprost works by increasing the natural outflow of fluid from the eye into the bloodstream. Timolol works by slowing the formation of fluid in the eye. Xalacom is used to reduce the pressure in your eye if you have conditions known as open angle glaucoma or ocular hypertension. Both these conditions are linked to an increase in the pressure within your eye, eventually affecting your eyesight. Your doctor will usually prescribe you Xalacom when other medicines have not worked adequately. Page 1 of 10
2 2. What you need to know before you use Xalacom Xalacom can be used in adult men and women (including the elderly), but is not recommended for use if you are less than 18 years of age. Do not use Xalacom eye drops solution: if you are allergic (hypersensitive) to either of the medicines in Xalacom (latanoprost or timolol), beta-blockers, or any of the other ingredients of Xalacom (listed in section 6) if you have now or have had in past respiratory problems such as asthma, severe chronic obstructive bronchitis (severe lung disease which may cause wheeziness, difficulty in breathing and/or long-standing cough) if you have serious heart problems or heart rhythm disorders Warnings and precautions Talk to your doctor or pharmacist before using Xalacom if you have now or have had in the past: coronary heart disease (symptoms can include chest pain or tightness, breathlessness or choking), heart failure, low blood pressure disturbances of heart rate such as slow heart beat breathing problems, asthma or chronic obstructive pulmonary disease poor blood circulation disease (such as Raynaud s disease or Raynaud s syndrome) diabetes as timolol may mask signs and symptoms of low blood sugar overactivity of the thyroid gland as timolol may mask signs and symptoms you are about to have any kind of eye surgery (including cataract surgery) or have had any kind of eye surgery in the past you suffer from eye problems (such as eye pain, eye irritation, eye inflammation or blurred vision) you know that you suffer from dry eyes you wear contact lenses. You can still use Xalacom but follow the instructions for contact lens wearers in section 3 you know that you suffer from angina (particularly a type known as Prinzmetal angina) Page 2 of 10
3 you know that you suffer from severe allergic reactions that would usually require hospital treatment you have suffered or are currently suffering from a viral infection of the eye caused by the herpes simplex virus (HSV) Tell your doctor before you have an operation that you are using Xalacom as timolol may change effects of some medicines used during anaesthesia. Other medicines and Xalacom Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including using eye drops and medicines obtained without a prescription. Xalacom can affect or be affected by other medicines you are using, including other eye drops for the treatment of glaucoma. Tell your doctor if you are using or intend to use medicines to lower blood pressure, heart medicine or medicines to treat diabetes. In particular, speak to your doctor or pharmacist if you know that you are taking any of the following types of medicine: Prostaglandins, prostaglandin analogues or prostaglandin derivates Beta-blockers Epinephrine Drugs used to treat high blood pressure such as oral calcium channel blockers, guanethidine, antiarrythmics, digitalis glycosides or parasympathomimetics Quinidine (used to treat heart conditions and some types of malaria) Antidepressants known as fluoxetine and paroxetine Xalacom with food and drink Normal meals, food or drink have no effect on when or how you should use Xalacom. Pregnancy, breast-feeding and fertility Pregnancy Do not use Xalacom if you are pregnant unless your doctor considers it necessary. Tell your doctor immediately if you are pregnant, think you are pregnant or are planning to become pregnant. Breast-feeding Do not use Xalacom if you are breast-feeding. Xalacom may get into your milk. Ask your doctor for advice before taking any medicine during breast-feeding. Page 3 of 10
4 Fertility Latanoprost and timolol have been found to have no effect on male or female fertility in animal studies. Driving and using machines When you use Xalacom your vision may become blurred for a short time. If this happens to you, do not drive or use any tools or machines until your vision becomes clear again. Xalacom contains benzalkonium chloride Xalacom contains a preservative called benzalkonium chloride. This preservative may cause eye irritation or disruption to the surface of the eye. It can be absorbed by contact lenses and is known to discolour soft contact lenses. Therefore, avoid contact with soft contact lenses. See the instructions for contact lens wearers in section How to use Xalacom Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. The recommended dose for adults (including the elderly) is one drop once a day in the affected eye(s). Do not use Xalacom more than once a day, because the effectiveness of the treatment can be reduced if you administer it more often. Use Xalacom as instructed by your doctor until your doctor tells you to stop. Your doctor may want you to have extra checks on your heart and circulation if you use Xalacom. Contact lens wearers If you wear contact lenses, you should remove them before using Xalacom. After using Xalacom you should wait 15 minutes before putting your contact lenses back in. Page 4 of 10
5 Instructions for use 1. Wash your hands and sit or stand comfortably. 2. Twist off the outer cap (which can be thrown away). Figure 1 3. Unscrew the protective inner cap. The protective cap should be retained. Figure 2 4. Use your finger to gently pull down the lower eyelid of your affected eye. 5. Place the tip of the bottle close to, but not touching your eye. 6. Squeeze the bottle gently so that only one drop goes into your eye, then release the lower eyelid. 7. After using Xalacom, press a finger into the corner of your eye, by the nose (figure 4) for 2 minutes. This helps to stop latanoprost + timolol getting into the rest of the body. Figure 3 Page 5 of 10
6 Figure 4 8. Repeat in your other eye if your doctor has told you to do this. 9. Put the protective inner cap back on the bottle. If you use Xalacom with other eye drops Wait at least 5 minutes between using Xalacom and using the other eye drops. If you use more Xalacom than you should If you put too many drops in your eye you may experience some minor irritation in your eye and your eyes may water and turn red. This should pass but if you are worried contact your doctor for advice. If you swallow Xalacom If you swallow Xalacom accidentally you should contact your doctor for advice. If you swallow a lot of Xalacom you may feel sick, have stomach pains, feel tired, flushed and dizzy and start to sweat. If you forget to use Xalacom Carry on with the usual dosage at the usual time. Do not use a double dose to make up to the dose you have forgotten. If you are unsure about anything talk to your doctor or pharmacist. 4. Possible side effects Like all medicines this medicine can cause side effects, although not everybody gets them. You can usually carry on using the drops, unless the effects are serious. If you're worried, talk to a doctor or pharmacist. Do not stop using Xalacom without speaking to your doctor. Listed below are the known side effects of using Xalacom. The most important side-effect is the possibility of a gradual, permanent change in your eye colour. It is also possible that Xalacom might cause serious changes in the way your heart works. If you notice changes in your heart rate or heart function you should speak to a doctor and tell them you have been using Xalacom. Page 6 of 10
7 The following are known side effects of using Xalacom: Very common (may affect more than 1 in 10 people): A gradual change in your eye colour by increasing the amount of brown pigment in the coloured part of the eye known as the iris. If you have mixed-colour eyes (blue-brown, grey-brown, yellow-brown or green-brown) you are more likely to see this change than if you have eyes of one colour (blue, grey, green or brown eyes). Any changes in your eye colour may take years to develop. The colour change may be permanent and may be more noticeable if you use Xalacom in only one eye. There appears to be no problems associated with the change in eye colour. The eye colour change does not continue after Xalacom treatment is stopped. Common (may affect up to 1 in 10 people): Eye irritation (a feeling of burning, grittiness, itching, stinging or the sensation of a foreign body in the eye) and eye pain. Uncommon (may affect up to 1 in 100 people): Headache Redness of the eye, eye infection (conjunctivitis), blurred vision, watery eyes, inflammation of the eyelids, irritation or disruption of the surface of the eye Skin rashes or itching (pruritus) Other side effects Like other medicines used in the eyes, Xalacom (latanoprost and timolol) is absorbed into the blood. The incidence of side effects after using eye drops is lower than when medicines are, for example, taken by mouth or injected. Although not seen with Xalacom, the following additional side effects have been seen with the medicines in Xalacom (latanoprost and timolol) and therefore might occur when you use Xalacom. The listed side effects include reactions seen within the class of beta-blockers (e.g. timolol) when used for treating eye conditions: Developing a viral infection of the eye caused by the herpes simplex virus (HSV). Generalized allergic reactions including swelling beneath the skin that can occur in areas such as the face and limbs and can obstruct the airway which may cause difficulty swallowing or breathing, hives or itchy rash, localized and generalized rash, itchiness, severe sudden life-threatening allergic reaction. Low blood glucose levels. Dizziness, difficulty sleeping (insomnia), depression, nightmares, memory loss. Page 7 of 10
8 Fainting, stroke, reduced blood supply to the brain, increases in signs and symptoms of myasthenia gravis (muscle disorder), unusual sensations like pins and needles, and headache. Swelling at the back of the eye (macular oedema), fluid filled cyst within the coloured part of the eye (iris cyst), light sensitivity (photophobia), sunken eye appearance (deepening of the eye sulcus). Signs and symptoms of eye irritation (e.g. burning, stinging, itching, tearing, redness), inflammation of the eyelid, inflammation in the cornea, blurred vision and detachment of the layer below the retina that contains blood vessels following filtration surgery which may cause visual disturbances, decreased corneal sensitivity, dry eyes, corneal erosion (damage to the front layer of the eyeball), drooping of the upper eyelid (making the eye stay half closed), double vision. Darkening of the skin around the eyes, changes to the eyelashes and fine hairs around the eye (increased number, length, thickness and darkening), changes to the direction of eyelash growth, swelling around the eye, swelling of the coloured part of the eye (iritis/uveitis), scarring of the surface of the eye. Whistling/ringing in the ears (tinnitus). Angina, worsening of angina in patients who already have heart disease. Slow heart rate, chest pain, palpitations (awareness of heart rhythm), oedema (fluid build-up), changes in the rhythm or speed of the heartbeat, congestive heart failure (heart disease with shortness of breath and swelling of the feet and legs due to fluid build-up), a type of heart rhythm disorder, heart attack, heart failure. Low blood pressure, poor blood circulation which makes the fingers and toes numb and pale, cold hands and feet. Shortness of breath, constriction of the airways in the lungs (predominantly in patients with pre-existing disease), difficulty breathing, cough, asthma, worsening of asthma. Taste disturbances, nausea, indigestion, diarrhoea, dry mouth, abdominal pain, vomiting. Hair loss, skin rash with white silvery coloured appearance (psoriasiform rash) or worsening of psoriasis, skin rash. Joint pain, muscle pain not caused by exercise, muscle weakness, tiredness. Sexual dysfunction, decreased libido. In very rare cases, some patients with severe damage to the clear layer at the front of the eye (the cornea) have developed cloudy patches on the cornea due to calcium build-up during treatment. Page 8 of 10
9 Reporting of side effects UK If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme website: By reporting side effects you can help provide more information on the safety of this medicine. Malta ADR Reporting Website: 5. How to store Xalacom Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated after EXP on the carton and bottle label. The expiry date refers to the last day of that month. Store the unopened bottle of Xalacom in a refrigerator (between 2 C to 8 C). After opening the bottle it is not necessary to store it in a refrigerator but do not store it above 25 C. After opening do not use this bottle for more than 4 weeks. When you are not using Xalacom, keep the bottle in the outer carton, in order to protect from light. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6. Contents of the pack and other information What Xalacom contains The active substances are latanoprost 50 micrograms/ml and timolol (as timolol maleate) 5 mg/ml. The other ingredients are: Sodium chloride Benzalkonium chloride Sodium dihydrogen phosphate monohydrate (E399i) Disodium phosphate anhydrous (E399ii) Hydrochloric acid solution (for adjustment to ph 6.0) Page 9 of 10
10 Sodium hydroxide solution (for adjustment to ph 6.0) Water for injections What Xalacom looks like and contents of the pack This pack contains one bottle containing 2.5 ml of Xalacom Eye Drops, Solution. Xalacom is a clear, colourless liquid. Xalacom is available in pack sizes of 1, 3 and 6 bottles. Not all pack sizes may be marketed. Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder: Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom Manufacturer: Pfizer Manufacturing Belgium NV, Rijksweg 12, 2870 Puurs, Belgium. This medicinal product is authorised in the Member States of the EEA under the following names Xalacom in Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, The Netherlands, Portugal, Slovakia, Slovenia, Spain and United Kingdom. Xalcom in Denmark, Finland, Iceland, Norway, Romania and Sweden. This leaflet was last revised in: 06/2017 Ref: XM 15_0 Page 10 of 10
Package leaflet: Information for the user. Xalatan 50 micrograms/ml Eye drops, solution Latanoprost
Package leaflet: Information for the user Xalatan 50 micrograms/ml Eye drops, solution Latanoprost Read all of this leaflet carefully before you start using this medicine because it contains important
More informationPackage leaflet: Information for the user. Latanoprost Pfizer 50 micrograms/ml Eye drops, solution Latanoprost
Package leaflet: Information for the user Latanoprost Pfizer 50 micrograms/ml Eye drops, solution Latanoprost Read all of this leaflet carefully before you start using this medicine because it contains
More informationPackage leaflet: Information for the user XATABLOC. 50 micrograms/ml + 5 mg/ml eye drops, solution latanoprost / timolol
Package leaflet: Information for the user XATABLOC 50 micrograms/ml + 5 mg/ml eye drops, solution latanoprost / timolol Read all of this leaflet carefully before you start using this medicine because it
More informationTIMALEN 0.5% eye drops
PACKAGE LEAFLET: INFORMATION FOR THE USER TIMALEN 0.5% eye drops TIMOLOL (AS TIMOLOL MALEATE) This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,
More informationPackage leaflet: Information for the user. GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution, in single-dose container Bimatoprost/timolol
Package leaflet: Information for the user GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution, in single-dose container Bimatoprost/timolol Read all of this leaflet carefully before you start using this medicine
More informationPackage leaflet: Information for the user. GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution Bimatoprost/timolol
Package leaflet: Information for the user GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution Bimatoprost/timolol Read all of this leaflet carefully before you start using this medicine because it contains
More informationPackage Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost
Package Leaflet: Information for the user LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost Read all of this leaflet carefully before you start using this medicine because it
More informationPackage leaflet: Information for the patient. Latanoprost 50 micrograms/ml eye drops, solution latanoprost
PACKAGE LEAFLET 18 Package leaflet: Information for the patient Latanoprost 50 micrograms/ml eye drops, solution latanoprost Read all of this leaflet carefully before you start using this medicine because
More informationPackage leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin
Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution Levofloxacin Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationPackage leaflet: Information for the patient BETAXOLOL 0.5% EYE DROPS. Betaxolol (as hydrochloride)
Package leaflet: Information for the patient BETAXOLOL 0.5% EYE DROPS Betaxolol (as hydrochloride) Read all of this leaflet carefully before you starts to using this medicine because it contains important
More informationPackage leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride
Package leaflet: Information for the user Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride Read all of this leaflet carefully before you start using this medicine because it contains important
More informationPackage leaflet: Information for the patient. Taptiqom 15 micrograms/ml + 5 mg/ml Eye drops, solution in single-dose container. Tafluprost/Timolol
Package leaflet: Information for the patient Taptiqom 15 micrograms/ml + 5 mg/ml Eye drops, solution in single-dose container Tafluprost/Timolol Read all of this leaflet carefully before you start using
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)
PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol) Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may
More informationPackage leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate
Package leaflet: Information for the patient Brimonidine Biogaran 2 mg/ml eye drops, solution brimonidine tartrate Read all of this leaflet carefully before you start using this medicine because it contains
More informationPackage leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac
Package leaflet: Information for the user NEVANAC 1 mg/ml eye drops, suspension Nepafenac Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationPATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops
Page 1 of 6 SCHEDULING STATUS Schedule 4 PATIENT INFORMATION LEAFLET PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops Read all of this leaflet carefully
More informationPackage leaflet: Information for the user. DuoTrav 40 micrograms/ml + 5 mg/ml eye drops, solution travoprost/timolol
Package leaflet: Information for the user DuoTrav 40 micrograms/ml + 5 mg/ml eye drops, solution travoprost/timolol Read all of this leaflet carefully before you start using this medicine because it contains
More informationPackage Leaflet: Information for the user. NEVANAC 3 mg/ml eye drops, suspension nepafenac
Package Leaflet: Information for the user NEVANAC 3 mg/ml eye drops, suspension nepafenac Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationDorzolamide 20 mg/ml Eye Drops, Solution
PACKAGE LEAFLET: INFORMATION FOR THE USER Dorzolamide 20 mg/ml Eye Drops, Solution (Dorzolamide hydrochloride) Read all of this leaflet carefully before you start using this medicine because it contains
More informationPackage leaflet: Information for the user. COMBIGAN 2 mg/ml + 5 mg/ml eye drops, solution Brimonidine tartrate and timolol
Package leaflet: Information for the user COMBIGAN 2 mg/ml + 5 mg/ml eye drops, solution Brimonidine tartrate and timolol Read all of this leaflet carefully before you start using this medicine because
More informationZanopro Plus 50micrograms/ml and 5mg/ml Eye Drops, Solution
PACKAGE LEAFLET: INFORMATION FOR THE USER Zanopro Plus 50micrograms/ml and 5mg/ml Eye Drops, Solution Latanoprost / Timolol Read all of this leaflet carefully before you start using this medicine because
More informationPATIENT INFORMATION LEAFLET
Page 1 of 6 PATIENT INFORMATION LEAFLET SCHEDULING STATUS Schedule 4 Proprietary name, Strength and Pharmaceutical Form LUMIGAN 0,03 % Eye Drops (each ml contains bimatoprost 0,3 mg) Read all of this leaflet
More informationPackage leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate
Package leaflet: Information for the user PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate Read all of this leaflet carefully before you start using this medicine
More informationPackage Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone
Package Leaflet - Information for the User TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone Read all of this leaflet carefully before you start using this medicine because it
More informationProposed PIL NL/H/0653/001/IB/024/G. MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate
Proposed PIL NL/H/0653/001/IB/024/G PACKAGE LEAFLET: INFORMATION FOR THE USER MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate Read all of this leaflet
More informationIOPIDINE 5mg/ml Eye Drops, solution contain apraclonidine (as hydrochloride) as the active substance.
Package Leaflet - Information for the User IOPIDINE 5 mg/ml eye drops, solution Apraclonidine (as hydrochloride) Read all of this leaflet carefully before you start using this medicine because it contains
More informationPRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate
Package leaflet: Information for the user PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate Read all of this leaflet carefully before you start using this medicine because it contains important
More information2 pl-timoptol-la-uk-appr
Package leaflet: Information for the patient Timoptol-LA 0.25% w/v gel-forming eye drops, solution Timoptol-LA 0.5% w/v gel-forming eye drops, solution timolol (as maleate) Read all of this leaflet carefully
More informationPackage leaflet: Information for the patient. IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin
Package leaflet: Information for the patient IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationPACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate)
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate) Pfizer Logo Read all of this leaflet carefully before you start taking this
More informationPilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER Pilocarpine 2% w/v Eye Drops, solution Pilocarpine 4% w/v Eye Drops, solution Pilocarpine Hydrochloride (Referred to as Pilocarpine Eye Drops in this leaflet)
More informationALPHAGAN EYE DROPS BRIMONIDINE TARTRATE
PACKAGE LEAFLET: INFORMATION FOR THE USER ALPHAGAN EYE DROPS BRIMONIDINE TARTRATE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which
More informationPackage leaflet: Information for the user. Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate
Package leaflet: Information for the user Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate Read all of this leaflet carefully before you start using this medicine because it contains
More information1. What Miacalcic is and what it is used for
Package leaflet: Information for the user Miacalcic 100 IU/ml solution for injection and infusion Calcitonin (salmon, synthetic) Read all of this leaflet carefully before you start using this medicine
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. T-LO Timolol Ophthalmic Solution (0.25%, 0.
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr T-LO Timolol Ophthalmic Solution (0.25%, 0.5% w/v) Pr TIMOLOL MALEATE-EX Timolol Ophthalmic Gel Forming Solution
More informationThis leaflet's format was set and its contents inspected and approved by the Ministry of Health
This leaflet's format was set and its contents inspected and approved by the Ministry of Health Patient leaflet in accordance with the Pharmacists Regulation (Preparations) 1986 The preparation shall be
More informationPackage leaflet: Information for the patient. Verkazia 1 mg/ml eye drops emulsion ciclosporin
Package leaflet: Information for the patient Verkazia 1 mg/ml eye drops emulsion ciclosporin Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationPackage leaflet: Information for the user. AZOPT 10 mg/ml eye drops, suspension Brinzolamide
Package leaflet: Information for the user AZOPT 10 mg/ml eye drops, suspension Brinzolamide Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationPackage leaflet: Information for the user. Zoviduo 50 mg/g and 10 mg/g cream. Aciclovir and Hydrocortisone
The PL includes alternative texts for different legal status in different countries as follows: -Boxed texts are only applicable for OTC versions. -[Grey-shaded texts in brackets] are only applicable for
More informationNORVASC 5 mg and 10 mg tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER NORVASC 5 mg and 10 mg tablets AMLODIPINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which
More informationPackage Leaflet : Information for the User. IOPIDINE 1%w/v eye drops solution (Apraclonidine Hydrochloride)
Package Leaflet : Information for the User IOPIDINE 1%w/v eye drops solution (Apraclonidine Hydrochloride) Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You
More informationPackage leaflet: Information for the patient. xylometazoline hydrochloride
Package leaflet: Information for the patient /.../ 0.5 mg/ml nasal spray, solution /.../ 1 mg/ml nasal spray, solution xylometazoline hydrochloride Read all of this leaflet carefully before you start using
More informationPackage leaflet: Information for the user. Carmellose sodium
Package leaflet: Information for the user CELLUVISC 0.5% w/v, eye drops, solution, unit dose Carmellose sodium Read all of this leaflet carefully before you start using this medicine because it contains
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER SALAGEN 5 mg film-coated tablets Pilocarpine hydrochloride Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may
More informationVentolin Injection 500 micrograms/ml salbutamol sulfate
Package leaflet: Information for the user Ventolin Injection 500 micrograms/ml salbutamol sulfate Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationTiorfan Hidrasec Tiorfix Tiorfast 100 mg PACKAGE LEAFLET
Tiorfix Tiorfast 100 mg PACKAGE LEAFLET 1 Tiorfix Tiorfast 100 mg Package leaflet: Information for the user 100 mg hard capsules Racecadotril Read all of this leaflet carefully before you start taking
More informationPackage leaflet: Information for the patient. Avodart 0.5 mg soft capsules dutasteride
Package leaflet: Information for the patient Avodart 0.5 mg soft capsules dutasteride Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPackage leaflet: Information for the user. <product name> 3 mg/ml eye drops, solution. Ofloxacin
Package leaflet: Information for the user 3 mg/ml eye drops, solution Ofloxacin Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
More informationPackage leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine
Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Always
More informationPackage leaflet: Information for the user. Norditropin SimpleXx 5 mg/1.5 ml solution for injection in cartridge somatropin
Package leaflet: Information for the user Norditropin SimpleXx 5 mg/1.5 ml solution for injection in cartridge somatropin Read all of this leaflet carefully before you start using this medicine because
More informationPackage Leaflet: Information for the Patient. FOSRENOL 750 mg oral powder. FOSRENOL 1000 mg oral powder. lanthanum
Package Leaflet: Information for the Patient FOSRENOL 750 mg oral powder FOSRENOL 1000 mg oral powder lanthanum Read all of this leaflet carefully before you start taking this medicine because it contains
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate
PACKAGE LEAFLET: INFORMATION FOR THE USER GRAZAX 75,000 SQ-T oral lyophilisate Standardised allergen extract of grass pollen from Timothy (Phleum pratense) Read all of this leaflet carefully before you
More informationPackage leaflet: Information for the patient. Hexvix 85 mg, powder and solvent for intravesical solution Hexaminolevulinate
Package leaflet: Information for the patient Hexvix 85 mg, powder and solvent for intravesical solution Hexaminolevulinate Read all of this leaflet carefully before you are given this medicine because
More informationCONSUMER INFORMATION. Sandoz Travoprost / Timolol PQ ophthalmic solution travoprost and timolol ophthalmic solution with POLYQUAD * as preservative
CONSUMER INFORMATION Pr Sandoz Travoprost / Timolol PQ ophthalmic solution travoprost and timolol ophthalmic solution with POLYQUAD * as preservative This leaflet is designed specifically for Consumers.
More informationPackage leaflet: Information for the patient. Brinzolamide 10 mg/ml Eye Drops, Suspension brinzolamide
Package leaflet: Information for the patient Brinzolamide 10 mg/ml Eye Drops, Suspension brinzolamide Read all of this leaflet carefully before you start using this medicine because it contains important
More informationPackage leaflet: Information for the user. Nasacort 55 micrograms/dose, nasal spray suspension Triamcinolone acetonide
Package leaflet: Information for the user 55 micrograms/dose, nasal spray suspension Triamcinolone acetonide Read all of this leaflet carefully before you start using this medicine because it contains
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Emerade 150 micrograms solution for injection in pre-filled pen Emerade 300 micrograms solution for injection in pre-filled pen Emerade 500 micrograms solution
More informationImodium 1 mg/5 ml oral solution
PACKAGE LEAFLET: INFORMATION FOR THE USER Imodium 1 mg/5 ml oral solution Loperamide hydrochloride Imodium is a registered trademark Read all of this leaflet carefully before you start using this medicine
More informationPackage leaflet: information for the user
Package leaflet: information for the user Valtrex 250 mg film-coated tablets Valtrex 500 mg film-coated tablets Valtrex 1000 mg film-coated tablets valaciclovir Read all of this leaflet carefully before
More informationSome general information on hepatitis A infection is given at the end of this leaflet.
Package Leaflet: Information for the User Havrix Monodose Vaccine Suspension for injection in a pre-filled syringe Hepatitis A (inactivated) vaccine (adsorbed) Read all of this leaflet carefully before
More informationPackage leaflet: Information for the user. Bricanyl Turbohaler 0.5 mg/dose terbutaline sulfate
Package leaflet: Information for the user Bricanyl Turbohaler 0.5 mg/dose terbutaline sulfate Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationPATIENT INFORMATION LEAFLET
Page 1 of 6 PATIENT INFORMATION LEAFLET SCHEDULING STATUS Schedule 4 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM PRED FORTE Sterile Eye Suspension, prednisolone acetate 10 mg/ml sterile eye suspension
More information1. What Panzyga is and what it is used for
Package leaflet: Information for the user Panzyga, 100 mg/ml solution for infusion Human Normal Immunoglobulin (IVIg) This medicine is subject to additional monitoring. This will allow quick identification
More informationPACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT ILAXTEN 20 MG TABLETS bilastine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Fibrovein 3%, 1%, 0.5% and 0.2% Solution for Injection Sodium tetradecyl sulphate
PACKAGE LEAFLET: INFORMATION FOR THE USER Fibrovein 3%, 1%, 0.5% and 0.2% Solution for Injection Sodium tetradecyl sulphate Read all of this leaflet carefully before you start using this medicine. Keep
More informationPackage leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin
Package leaflet: Information for the user Dalmevin 50 mg tablets Vildagliptin Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationPackage leaflet: Information for the patient. / / 30 mg/5 ml syrup. Ambroxol hydrochloride
Package leaflet: Information for the patient / / 30 mg/5 ml syrup Ambroxol hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPackage leaflet: Information for the patient
Page 1 of 5 Package leaflet: Information for the patient Xyzal 5 mg/ml oral drops, solution For adults and children aged 2 years and above Levocetirizine dihydrochloride Read all of this leaflet carefully
More information2. What you need to know before you take Tenormin
Package leaflet: Information for the patient Tenormin LS 50 mg Tablets atenolol Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationPackage leaflet: Information for the user. Pravastatin Actavis 20 mg and 40 mg tablets (pravastatin sodium)
PACKAGE LEAFLET Package leaflet: Information for the user Pravastatin Actavis 20 mg and 40 mg tablets (pravastatin sodium) Read all of this leaflet carefully before you start taking this medicine because
More informationPackage leaflet: Information for the User Clarityn 10 mg tablets Loratadine
Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Always
More informationPharmaceutical form(s)/strength: Solution: 5 mg/ml Suspensions: 2.5 and 5 mg/ml P-RMS:
0BCore Safety Profile Active substance: Betaxolol eyedrops Pharmaceutical form(s)/strength: Solution: 5 mg/ml Suspensions: 2.5 and 5 mg/ml P-RMS: HU/H/PSUR/0010/002 Date of FAR: 20.03.2013 4.2 Posology
More informationPackage leaflet: Information for the user. Bupivacaine 0.25% w/v, 0.5% w/v solution for injection Bupivacaine Hydrochloride
Package leaflet: Information for the user Bupivacaine 0.25% w/v, 0.5% w/v solution for injection Bupivacaine Hydrochloride Read all of this leaflet carefully before you start using this medicine because
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Alfuzosin Sandoz 5 mg, prolonged-release tablets. Alfuzosin hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER Alfuzosin Sandoz 5 mg, prolonged-release tablets Alfuzosin hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains
More informationPackage leaflet: Information for the user. Zidoval 7.5 mg/g Vaginal Gel Metronidazole
Package leaflet: Information for the user Zidoval 7.5 mg/g Vaginal Gel Metronidazole Read all of this leaflet carefully before you start using this medicine because it contains important information for
More informationPackage Leaflet: Information for the Patient. FOSRENOL 750 mg chewable tablets. FOSRENOL 1000 mg chewable tablets. lanthanum
Package Leaflet: Information for the Patient FOSRENOL 250 mg chewable tablets FOSRENOL 500 mg chewable tablets FOSRENOL 750 mg chewable tablets FOSRENOL 1000 mg chewable tablets lanthanum Read all of this
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium
PACKAGE LEAFLET: INFORMATION FOR THE USER Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium Read all of this leaflet carefully before you start taking this medicine because it contains
More informationPackage leaflet: Information for the patient. Xemacort 20 mg/g + 1 mg/g cream (fusidic acid and betamethasone)
PACKAGE LEAFLET Package leaflet: Information for the patient Xemacort 20 mg/g + 1 mg/g cream (fusidic acid and betamethasone) Read all of this leaflet carefully before you start using this medicine because
More informationSibelium 5 mg Tablets flunarizine
J-C 2017 Sibelium 5 mg Tablets flunarizine PACKAGE LEAFLET: INFORMATION FOR THE USER Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Nicorandil 10 mg Tablets Nicorandil 20 mg Tablets nicorandil
PACKAGE LEAFLET: INFORMATION FOR THE USER Nicorandil 10 mg Tablets Nicorandil 20 mg Tablets nicorandil Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Adrenaline
PACKAGE LEAFLET: INFORMATION FOR THE USER Jext 150 micrograms solution for injection in pre-filled pen Jext 300 micrograms solution for injection in pre-filled pen Adrenaline Read all of this leaflet carefully
More informationPackage leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime
Package leaflet: Information for the user Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationTENOPT timolol maleate
TENOPT timolol maleate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about It does not contain all the available information. It does not take the place
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER ALBUNORM 20% 200 g/l, Solution for infusion Human albumin
PACKAGE LEAFLET: INFORMATION FOR THE USER ALBUNORM 20% 200 g/l, Solution for infusion Human albumin Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need
More informationPackage leaflet: Information for the patient
Package leaflet: Information for the patient Trulicity 0.75 mg solution for injection in pre-filled pen Trulicity 1.5 mg solution for injection in pre-filled pen dulaglutide This medicine is subject to
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Femara 2.5 mg film-coated tablets letrozole Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPackage leaflet: Information for the user. Optilamid 10 mg/ml, oogdruppels, suspensie Brinzolamide
Package leaflet: Information for the user Optilamid 10 mg/ml, oogdruppels, suspensie Brinzolamide Read all of this leaflet carefully before you start taking this medicine because it contains important
More information1 What Engerix B is and what it is used for
Package leaflet: Information for the user ENGERIX B 20 micrograms/1 ml, suspension for injection Hepatitis B (rdna) vaccine (adsorbed) (HBV) Read all of this leaflet carefully before you start receiving
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral)
PACKAGE LEAFLET: INFORMATION FOR THE USER DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral) Read all of this leaflet carefully before you start using
More informationPackage leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide
Package leaflet: Information for the user Flutamid Stada 250 mg tablets Flutamide Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationPatient Information COSOPT PF (CO-sopt PEA EHF) (dorzolamide hydrochloride-timolol maleate ophthalmic solution) 2%/0.5%
Patient Information COSOPT PF (CO-sopt PEA EHF) (dorzolamide hydrochloride-timolol maleate ophthalmic solution) 2%/0.5% Read this information before you start using COSOPT PF and each time you get a refill.
More informationPackage leaflet: Information for the user Salofalk 500mg gastro-resistant tablets Mesalazine
Package leaflet: Information for the user Salofalk 500mg gastro-resistant tablets Mesalazine Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP Read this carefully before you start taking IOPIDINE 1% and each
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET: INFORMATION FOR THE USER DYSPORT 500 units Powder for solution for injection Clostridium botulinum type A toxin-haemagglutinin complex Read all of this leaflet carefully, before you start
More information1. What Naropin is and what it is used for
Package leaflet: Information for the user Naropin 2 mg/ml, 7.5 mg/ml, 10 mg/ml solution for injection Naropin 2 mg/ml solution for infusion Ropivacaine hydrochloride Read all of this leaflet carefully
More informationPackage leaflet: Information for the user. Exembol 1 mg/ml solution for infusion. argatroban monohydrate
Package leaflet: Information for the user Exembol 1 mg/ml solution for infusion argatroban monohydrate Read all of this leaflet carefully before you start using this medicine because it contains important
More informationZofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.
GlaxoSmithKline (logo) Package Leaflet: Information for the User Zofran 4 mg/5 ml Syrup Ondansetron Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPravat 40 mg tablets. Pravastatin sodium
Package leaflet: Information for the patient Pravat 10 mg tablets Pravat 20 mg tablets Pravat 40 mg tablets Pravastatin sodium Read all of this leaflet carefully before you start taking this medicine because
More information